TB-500 10 MG

Product information

Identity and experimental mechanisms

Here TB-500 denotes full-length, N-terminally acetylated thymosin β4, not the shorter fragment sometimes sold under that name. Tβ4 binds monomeric actin and helps regulate its availability for cell movement. The page discusses endothelial and skin-cell experiments and animal models of skin wounds, ischemia, cardiac injury, corneal injury and neurological injury.

Evidence and handling boundaries

Animal observations do not establish faster recovery or clinical benefits in people. Early studies of pharmaceutical Tβ4 are distinguished from research-supplier TB-500, which has no approved human use in the page's account. Long-term safety remains uncertain. The source also discusses the Ac-SDKP fragment, differing experimental protocols, batch traceability and dry, cold, light-protected storage.

Specifications